Heparin inhibits human coronary artery smooth muscle cell migration

Metabolism: Clinical and Experimental

Volumn 47, Issue 9, 1998, Pages 1065-1069

  Kohno, Masakazu ^a   Yokokawa, Koji ^b   Yasunari, Kenichi ^b   Minami, Mieko ^b   Kano, Hiroaki ^b   Mandal, Anil K ^b   Yoshikawa, Junichi ^b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR;

ANTICOAGULATION; ARTERY INTIMA PROLIFERATION; ARTERY MUSCLE; ARTICLE; BLOOD VESSEL INJURY; CELL COUNT; CELL CULTURE; CELL MIGRATION; CORONARY ARTERY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0031723335     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90279-7     Document Type: Article

References (46)

1. Clowes AW, Schwartz SM: Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res 56:139-145, 1985
2. Ross R: The pathogenesis of atherosclerosis - An update. N Engl J Med 314:488-500, 1986
3. Grotendorst GR, Seppa HEJ, Kleinman HK, et al: Attachment of smooth muscle cells to collagen and their migration toward plateletderived growth factor. Proc Natl Acad Sci USA 78:3669-3672, 1981
4. Ikeda M, Kohno M, Yasunari K, et al: Natriuretic peptide family as a novel antimigration factor of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17:731-736, 1997
5. Koyama N, Koshikawa T, Morisaki N, et al: Bifunctional effects of transforming growth factor-β on migration of cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 169:725-729, 1990
6. Naito M, Hayashi T, Kuzuya M, et al: Fibrinogen is chemotactic for vascular smooth muscle cells. FEBS Lett 247:358-360, 1989
7. Autio I, Jaakkola O, Solakivi T, et al: Oxidized low density lipoprotein is chemotactic for arterial smooth muscle cells in culture. FEBS Lett 277:247-2491, 1990
8. Kohno M, Yokokawa K, Yasunari K, et al: Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells. Circ Res 81:585-590, 1997
9. Dubey RK, Jackson EK, Lücher TF: Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell: Role of cyclic nucleotides and angiotensin I receptors. J Clin Invest 96:141-149, 1995
10. Kohno M, Yokokawa K, Kano H, et al: Adrenomedullin is a potent inhibitor of angiotensin II-induced migration of human coronary artery smooth muscle cells. Hypertension 29:1309-1313, 1997
11. Clowes AW, Karnovsky MJ: Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 265:625-626, 1977
12. Castellot JJ Jr, Addonizio ML, Rosenberg R, et al: Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth. J Cell Biol 90:372-377, 1981
13. Reilly CF, Fritze LMS, Rosenberg RD: Heparin inhibition of smooth muscle cell proliferation: A cellular site of action. J Cell Physiol 129:11-19, 1986
14. Majack RA, Clowes AW: Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol 118:253-256, 1984
15. Clowes AW, Clowes MM: Kinetics of cellular proliferation after arterial injury, IV. Heparin inhibits rat smooth muscle mitogenesis and migration. Circ Res 58:839-845, 1986
16. Hoover RL, Rosenberg R, Haering W, et al: Inhibition of rat arterial smooth muscle cell proliferation by heparin, II: In vitro studies. Circ Res 47:578-583, 1980
17. Guyton JR, Rosenberg RD, Clowes AW, et al: Inhibition of rat arterial smooth muscle cell proliferation by heparin, I: In vivo studies with anticoagulant and nonanticoagulant heparin. Circ Res 46:625-634, 1980
18. Castellot JJ Jr, Cochran DL, Karnovsky MJ: Effect of heparin on vascular smooth muscle cell, I: Cell metabolism. J Cell Physiol 124:21-28, 1985
19. Majesky MW, Schwartz, SM, Clowes MM, et al: Heparin regulates smooth muscle S phase entry in the injured rat carotid artery. Circ Res 61:296-300, 1987
20. Edelman ER, Adams DH, Karnovsky MJ: Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc Natl Acad Sci USA 87:3773-3777, 1990
21. Gimple LW, Gertz SD, Haber HL, et al: Effect of chronic subcutaneous or intramural administration of heparin on femoral artery restenosis after balloon angioplasty in hypercholesterolemic rabbits. Circulation 86:1536-1546, 1992
22. Buchwald AB, Unterberg C, Nebendahl K, et al: Low-molecular-weight heparin reduces neointimal proliferation after coronary stent implantation in hypercholesterolemic minipigs. Circulation 86:531-537, 1992
23. Currier JW, Pow TK, Haudenschild CC, et al: Low molecular weight heparin (enoxaparin) reduces restenosis after iliac angioplasty in the hypercholesterolemic rabbit. J Am Coll Cardiol 17:118B-125B, 1991 (suppl B)
24. Susie D, Mandal AK, Kentera D: Heparin lowers the blood pressure in hypertensive rats. Hypertension 4:681-685, 1982
25. Wilson SK, Solez K. Boitnott J, et al: The effect of heparin treatment on hypertension and vascular lesions in stroke-prone spontaneously hypertensive rats. Am J Physiol 102:62-71, 1981
26. Pukac LA, Castellot JJ Jr, Wright TC, et al: Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells. Cell Regul 1:435-443, 1990
27. Yokokawa K, Mandal AK, Kohno M, et al: Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rats. Am J Physiol 263:R1035-R1041, 1992
28. Yokokawa K, Kohno M, Mandai AK, et al: Heparin suppresses endothelin-1 peptide and mRNA expression in cultured endothelial cells of spontaneously hypertensive rats. J Am Soc Nephrol 4:1683-1689, 1994
29. Yokokawa K, Tahara H, Kohno M, et al: Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells. J Clin Invest 92:2080-2085, 1993
30. Castellot JJ Jr, Pukac LA, Caleb BL, et al: Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells. J Cell Biol 109:3147-3155, 1989
31. Au YP, Montgomery KF, Clowes AW: Heparin inhibits collagenase gene expression mediated by phorbol ester-responsive element in primate arterial smooth muscle cells. Circ Res 70:1062-1069, 1992
32. Kohno M, Yokokawa K, Horio T, et al: Heparin inhibits endothelin-1 production in cultured rat mesangial cells. Kidney Int 45:137-142, 1994
33. Ellis SG, Roubin GS, Wilentz J, et al: Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 177:777-782, 1989
34. Faxon DP, Spiro TE, Minor S, et al: Low molecular weight heparin in prevention of restenosis after angioplasty: Results of enoxaparin restenosis (ERA) trial. Circulation 90:908-914, 1994
35. Laskey MAL, Deutsch E, Hirshfeld JW Jr, et al: Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in patients with coronary arterial thrombus. Am J Cardiol 65:179-182, 1990
36. Lehman KG, Doria RJ, Feuer JM, et al: Paradoxical increase in restenosis rate with chronic heparin use: Final results of a randomized trial. J Am Coll Cardiol 17:181, 1991 (abstr)
37. Saenz CB, Baxley WA, Bulle TM, et al: Early and late effect of heparin infusion following elective angioplasty. Circulation 78:II-98, 1988 (suppl 2, abstr)
38. Yasunari K, Kohno M, Balmforth A, et al: Glucocorticoids and dopamine-I receptors on vascular smooth muscle cells. Hypertension 13:575-581, 1989
39. Koyama N, Harada K, Yamamoto A, et al: Purification and characterization of an autocrine migration factor for vascular smooth muscle cells (SMC), SMC-derived migration factor. J Biol Chem 268:13301-13308, 1993
40. Horio T, Kohno M, Kano H, et al: Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ Res 77:660-664, 1995
41. Wallenstein S, Zucker CL, Fleiss JL: Some statistical methods useful in circulation research. Circ Res 47:1-9, 1980
42. Geary RL, Koyama N, Wang TW, et al: Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries: The role of heparin-sensitive and insensitive pathways in the stimulation of smooth muscle cell migration and proliferation. Circulation 91:2972-2981, 1995
43. Clowes AW, Clowes MM: Heparin inhibits injury-induced arterial smooth muscle migration and proliferation. Fed Proc 43:1022, 1984
44. Hoover RL, Rosenberg R, Haering W, et al: Inhibition of rat arterial smooth muscle cell proliferation by heparin, II: In vitro studies. Circ Res 47:578-583, 1980
45. Ross R, Glomset J, Kariya B, et al: A platelet dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 71:1207-1210, 1974
46. Ross R, Bowen-Pope DF, Raines EW: Platelets, macrophages, endothelium, and growth factors; their effects upon cells and their possible roles in atherogenesis. Ann NY Acad Sci 45:254-260, 1985